NCT03393741 2024-06-25
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
University of Wisconsin, Madison
Terminated
Clinical Trials
4 trialsNCT05764941 2023-03-27
Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT02619929 2018-08-29
StepUp
Pierre Fabre Pharma GmbH
Completed
NCT00235235 2015-12-09
A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
Hoosier Cancer Research Network
Terminated